Gellycle

Gellycle develops proprietary hydrogel technology called TetraGel, a biocompatible soft material engineered for precise control over physical properties to enable applications in biological systems. Using a platform business model, the company is developing a pipeline of medical products including hemostatic agents, anti-adhesion materials and nerve-regeneration scaffolds, and has extended its hydrogel applications into industrial and agricultural markets. Gellycle positions itself as a pioneer in high-performance soft materials for medical engineering and biotechnology, aiming to replace hard materials with adaptable gels across clinical and commercial use cases.